Pharmaceutical News

RSS

Automated kiosks can improve medication adherence

Ever see long lines at the pharmacy counter and give up on a medication, or find that the drive is just a little too long?

10 Dec 2020

New survey to understand the prevalence of marijuana use among cancer patients

Marijuana use is illegal in South Carolina, even for medical purposes. But national survey data shows that the use of marijuana for medical reasons is common, regardless of whether the people who use it live in a state with a legal marketplace.

10 Dec 2020

Antiepileptic drug reduces early signs of clinical dysfunction in people with ALS

The antiepileptic drug ezogabine reduced pathologic excitability of cortical and spinal motor neuron cells that are early signs of clinical dysfunction in people with amyotrophic lateral sclerosis (ALS), according to a study conducted by the Neurological Clinical Research Institute of Massachusetts General Hospital.

10 Dec 2020

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

As part of its Wave 1 Pipeline Market Opportunity Call, Takeda Pharmaceutical Company Limited provided an update on its pipeline portfolio, which has the potential to contribute significantly to revenue growth for the company over the next decade.

From Takeda 10 Dec 2020

Study examines effect of low-dose vancomycin to treat clostridium difficile infection

Clostridium difficile infection (CDI) is inflammation of the colon caused by a bacteria called clostridium difficile and is the most common cause of infectious diarrhea in hospitalized patients.

8 Dec 2020

Oligourea-based "fake" peptides enhance options for rational drug design, shows study

Some useful drugs consist of peptides acting on their protein targets. To make them more efficient and stable, scientists have found a way to replace crucial segments of the peptides with ureido units.

8 Dec 2020

Drug prescribed for rare enzyme deficiency shows promise to treat herpes viruses

A drug currently prescribed to treat a rare enzyme deficiency can help cells clear the herpes simplex 1 and herpes simplex 2 viruses, according to a new study published in the journal Science Advances.

7 Dec 2020

West Health Policy Center forms CIDSA to provide independent analysis of drug pricing policies

The West Health Policy Center, a nonprofit and nonpartisan policy research and education organization, announced today the formation of the Council for Informed Drug Spending Analysis, a group made up entirely of leading policy experts from the worlds of academia and healthcare.

7 Dec 2020

Secukinumab for treatment of plaque psoriasis in children: Added benefit not proven

The monoclonal antibody secukinumab is approved for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of six years who are candidates for systemic therapy.

5 Dec 2020

Study shows metformin can significantly reduce COVID-19 death risks in women

University of Minnesota Medical School and UnitedHealth Group researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of COVID-19 patients.

3 Dec 2020

FDA launches pilot program to help reduce and replace animal testing in drug development

This week, the U.S. Food and Drug Administration launched Innovative Science and Technology Approaches for New Drugs (ISTAND), a pilot program that will help reduce and replace animal testing as part of drug development.

3 Dec 2020

Can melatonin help prevent severe COVID-19?

A team of researchers at the University of Toronto in Canada has found that melatonin can be an adjuvant to augment the efficacy of anti-SARS-CoV-2 vaccines. They believe that the drug is a potential “silver bullet” to combat the COVID-19 pandemic.

3 Dec 2020

CUNY SPH launches new initiative to address public concerns about COVID-19 vaccines

The City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) today launched CONVINCE USAsm, part of a global project to increase understanding of factors that influence people's willingness to accept new COVID-19 vaccines, and to promote inclusive public dialogue to reduce vaccine hesitancy.

3 Dec 2020

Despite new CDC guidance, opioid prescription rates have not declined

Research from Saint Louis University finds that among patients at risk for opioid misuse, the odds of receiving a schedule II opioid for non-cancer pain were similar to those not at risk, despite new prescribing guidelines from the Centers for Disease Control (CDC).

2 Dec 2020

The UK approves Pfizer vaccine for December 2020 roll out

The UK approves Pfizer vaccine and schedules phased vaccination process, commencing December 2020.

2 Dec 2020

Mobile health app can improve HPV vaccine uptake in adolescents

More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals.

2 Dec 2020

Researchers develop first report card on biosimilars for three blockbuster cancer drugs

Researchers have developed the first report card on biosimilars for three blockbuster cancer drugs marketed by Genentech/Roche: Rituxan, Avastin, and Herceptin.

2 Dec 2020

Improved understanding of exposome-drug interactions could help prescribe effective drug doses

According to scientific estimations, humans are exposed to at least 10,000 to 100,000 environmental and exogenous compounds in an individual lifetime, which are mainly absorbed through our dietary.

2 Dec 2020

New combination therapy may help fight antimicrobial resistance

An inexpensive, FDA-approved drug -- cholestyramine -- taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. The team's findings appear today (Dec. 1) in the journal eLife.

2 Dec 2020

Study evaluates the performance of meningococcus B vaccine in real-world setting

Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero.

2 Dec 2020

Pharmaceutical News

Automated kiosks can improve medication adherence

New survey to understand the prevalence of marijuana use among cancer patients

Antiepileptic drug reduces early signs of clinical dysfunction in people with ALS

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

Study examines effect of low-dose vancomycin to treat clostridium difficile infection

Oligourea-based "fake" peptides enhance options for rational drug design, shows study

Drug prescribed for rare enzyme deficiency shows promise to treat herpes viruses

West Health Policy Center forms CIDSA to provide independent analysis of drug pricing policies

Secukinumab for treatment of plaque psoriasis in children: Added benefit not proven

Study shows metformin can significantly reduce COVID-19 death risks in women

FDA launches pilot program to help reduce and replace animal testing in drug development

Can melatonin help prevent severe COVID-19?

CUNY SPH launches new initiative to address public concerns about COVID-19 vaccines

Despite new CDC guidance, opioid prescription rates have not declined

The UK approves Pfizer vaccine for December 2020 roll out

Mobile health app can improve HPV vaccine uptake in adolescents

Researchers develop first report card on biosimilars for three blockbuster cancer drugs

Improved understanding of exposome-drug interactions could help prescribe effective drug doses

New combination therapy may help fight antimicrobial resistance

Study evaluates the performance of meningococcus B vaccine in real-world setting

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News